🚀 Gate Square “Gate Fun Token Challenge” is Live!
Create tokens, engage, and earn — including trading fee rebates, graduation bonuses, and a $1,000 prize pool!
Join Now 👉 https://www.gate.com/campaigns/3145
💡 How to Participate:
1️⃣ Create Tokens: One-click token launch in [Square - Post]. Promote, grow your community, and earn rewards.
2️⃣ Engage: Post, like, comment, and share in token community to earn!
📦 Rewards Overview:
Creator Graduation Bonus: 50 GT
Trading Fee Rebate: The more trades, the more you earn
Token Creator Pool: Up to $50 USDT per user + $5 USDT for the first 50 launche
Johnson & Johnson announced the launch of Evusheld injection in China.
On April 12, Jin10 reported that Johnson & Johnson announced the official launch of its innovative lung cancer treatment drug Ruko (Avelumab injection) in China. Ruko is administered in combination with carboplatin and pemetrexed and is indicated for first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer confirmed to carry epidermal growth factor receptor (EGFR) exon 20 insertion mutations.